Abstract
Introduction: Current laser treatments for acquired melanocytic nevi are unpredictable in terms of efficiency and cause considerable scarring. This study aimed to assess the efficacy and safety of the long-pulsed 532-nm Nd:YAG laser for removing small acquired melanocytic nevi in Yemeni patients. Methods and materials: From January 2004 to 2012, 350 patients (M:F; 41:309) with Fitzpatrick skin type IV and 1 or more small acquired melanocytic nevi were included in the study. The patients were exposed to the following laser parameters: wavelength, 532 nm; pulse duration, 20 ms; spot size, 2 mm; fluence, 30–50 j/cm2. Photographs were taken on 0, 1, 4, and 12 weeks posttreatment. The follow-up period ranged from 12 weeks to 5 years. Results: All nevi were completely removed with good to excellent cosmetic results in only one session. Side effects were seen in 30% of patients; the majority was temporary and, very mild in intensity, such as postinflammatory hyperpigmentation. Atrophic and hypertrophic scars were observed in 9.4% and 0.6% of cases, respectively. Recurrence was seen within 2–6 months after laser treatment in 25 patients. Conclusion: The long-pulsed, 532-nm Nd:YAG laser is safe and effective in the removal of small acquired melanocytic nevi in Yemeni patients.

This publication has 21 references indexed in Scilit: